QA: Johnson Johnson in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000200406_2026_Johnson_Johnson.pdf

Logs

Graph

Absolute values for 0000200406, Johnson Johnson

  xvar xval
0 AssetsCurrent 55,624,000,000
1 IntangibleAssetsNetIncludingGoodwill 99,175,000,000
2 PropertyPlantAndEquipmentNet 23,169,000,000
3 remainder_Assets 21,242,000,000
4 LiabilitiesCurrent 54,126,000,000
5 LiabilitiesNoncurrent 49,306,000,000
6 remainder_Liabilities 14,234,000,000
7 CostOfGoodsAndServicesSold 30,241,871,057
8 SellingGeneralAndAdministrativeExpense 23,641,884,290
9 ResearchAndDevelopmentExpense 14,701,771,206
10 remainder_Expenses 7,222,459,225
11 remainder_Revenues 94,092,356,511
12 remainder_NetIncome 2,157,675,808
13 remainder_ComprehensiveNetIncome -2,145,103,593
  yvar yval
0 Assets 199,210,000,000
1 Liabilities 117,666,000,000
2 Expenses 75,807,985,778
3 Revenues 94,092,356,511
4 StockholdersEquity 81,544,000,000
5 NetIncome 20,442,046,541
6 ComprehensiveNetIncome 19,369,494,744
7 BaseVar 245,539,560,845
8 EconomicCapitalRatiobeforeLimitedLiability 1.24
9 EconomicCapitalRatio 2.49

Edgar->Model Mapping

Feature Distribution

Change over Time